Developed by Johnson & Johnson, guselkumab (GUS) is the first approved fully-human, dual-acting IL-23p19 subunit inhibitor that blocks IL-23 and binds to CD64, a receptor on cells that produce IL-23.

Struggling to transfer ebooks to your Kindle? Here's the step-by-step process for moving EPUB, MOBI, and PDF files to both ...

With Amazon quietly killing a key Kindle feature, you might be seeking out alternatives — here are a few options ...

Foxit, a leading provider of innovative PDF and eSignature products and services, helping knowledge workers to increase productivity and do more with documents, today announced the addition of ...

Marx failed to grasp that there are laws of human action that apply universally. His understanding of economics was far inferior to that of Nassau Senior, whom ...

It's easy to take the internet for granted, but it might not always be around. Here's what I have saved on a rugged SSD to ...

The CBSE Class 12 Business Studies Question Paper 2025 followed the sample paper pattern, with a mix of theory and case-based questions.

If you're an avid e-book reader or someone who has an extensive library of Kindle content, now is the time to back up your ...

I was reminded that deadlines are not suggestions. Imperial College London is a place of purpose. Underneath us all hums the constant note of motion and progress. The students here are not simply ...

A multi-omics study reveals that impaired branched-chain amino acid (BCAA) catabolism is a key driver of sarcopenia, ...

First came Tetris, then Doom – and now a bare-bones Linux instance that boots inside a PDF.

ZDNET's editorial team writes on behalf of you, our reader. Our goal is to deliver the most accurate information and the most knowledgeable advice possible in order to help you make smarter buying ...